Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:59 PM
1.12
1.36%
After-hours: Aug 15, 2025, 07:51 PM EDT
Allogene Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -236.91M | -252.32M | -257.59M | -286.91M | -281.93M | -293.56M | -327.26M | -332.86M | -354.69M | -351.49M | -332.63M | -312.65M | -307.69M | -303.84M | -257M | -250.71M | -238.72M | -228.76M |
Depreciation & Amortization | 12.64M | 13.18M | 13.64M | 13.88M | 14.25M | 14.25M | 14.2M | 13.79M | 14.08M | 14.11M | 14.29M | 15.47M | 13.94M | 12.23M | 10.45M | 8.06M | 7.54M | 7.46M |
Stock-Based Compensation | 47.12M | 51.99M | 51.74M | 54.1M | 56.07M | 59.1M | 65.95M | 67.96M | 73.76M | 80.06M | 83.6M | 88.39M | 88.1M | 86.34M | 80.82M | 75.23M | 72.2M | 67.84M |
Other Working Capital | 33.65M | 2.14M | 5.77M | -2.56M | -41.9M | -18.45M | -7.8M | 3.17M | 14.14M | 17.93M | -7.88M | -13.82M | -10.69M | -7.39M | -31.32M | 2.8M | 4.65M | 12.01M |
Other Non-Cash Items | -22.09M | -11.6M | -13.36M | -15.15M | 602K | -1.56M | 2.78M | 9.66M | 10.07M | 10.51M | 13.7M | 6.73M | 6.41M | 6.2M | 2.61M | 5.34M | 5.29M | 5.24M |
Deferred Income Tax | n/a | n/a | n/a | 20.17M | 21.77M | 21.91M | 21.91M | -3.59M | -5.19M | -5.33M | -5.33M | 3.27M | 5.8M | 8.16M | 10.4M | 9.72M | 8.77M | 6.78M |
Change in Working Capital | 26.46M | 1.42M | 5.27M | -3.4M | -39.48M | -27.13M | -15.3M | -1.09M | 21.58M | 31.08M | 3.71M | -7.21M | -11.63M | -12.81M | -32.09M | 3.01M | 6.86M | 17.82M |
Operating Cash Flow | -172.77M | -197.33M | -200.3M | -217.31M | -228.72M | -226.99M | -237.73M | -246.12M | -238.25M | -218.92M | -220.52M | -203.86M | -205.08M | -203.72M | -184.81M | -149.35M | -138.06M | -123.61M |
Capital Expenditures | -829K | -785K | -694K | -618K | -201K | -489K | -1.52M | -3.03M | -3.24M | -4.32M | -5.19M | -4.24M | -7.36M | -16.89M | -21.45M | -38.11M | -55.01M | -60.17M |
Cash Acquisitions | n/a | n/a | n/a | -67.64M | -33.39M | -50.84M | -164.81M | -148.45M | -182.71M | -220.67M | -106.7M | -57.18M | -57.18M | -1.77M | -17.71M | -15.94M | -15.94M | -15.94M |
Purchase of Investments | -297.88M | -330.57M | -361.48M | -383.2M | -391.85M | -484.67M | -438.63M | -417.72M | -267.76M | -194.05M | -248.11M | -251.1M | -347.06M | -465.69M | -525.58M | -656.96M | -724.8M | -1.06B |
Sales Maturities Of Investments | 327.66M | 391.08M | 437.86M | 472.04M | 522M | 557.64M | 603.43M | 566.17M | 475.59M | 439.84M | 359.46M | 342.92M | 430.11M | 528.83M | 728.39M | 867.63M | 856M | 746.41M |
Other Investing Acitivies | n/a | n/a | n/a | 67.64M | 33.39M | 50.84M | 164.81M | 148.45M | 207.84M | 245.79M | 111.35M | 90.05M | 81.28M | 61.37M | 185.1M | 194.73M | 115.26M | -333.15M |
Investing Cash Flow | 28.95M | 59.73M | 75.69M | 88.22M | 129.94M | 72.49M | 163.29M | 145.43M | 204.6M | 241.47M | 106.16M | 85.81M | 73.92M | 44.48M | 163.66M | 156.62M | 60.25M | -393.32M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 638K | 638K | n/a | n/a | n/a | n/a | 1.73M | 4.19M | 4.19M | 4.19M | 3.99M | 5.15M | 5.15M | 5.15M | 5.6M | 1.98M | 1.98M | 1.98M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.06M | 6.29M | 2.3M | 2.3M | 3.39M | 90.61M | 92.35M | 92.39M | 92.37M | 2.87M | 2.95M | 3.23M | 4.54M | 7.73M | 11.96M | 13.26M | 14.7M | 15.96M |
Financial Cash Flow | 25.48M | 129.01M | 116.67M | 111.09M | 114.69M | 95.61M | 95.69M | 95.59M | 92.37M | 2.87M | 2.95M | 3.23M | 4.54M | 7.73M | 11.96M | 24.62M | 26.09M | 623.05M |
Net Cash Flow | -118.33M | -8.58M | -7.94M | -18.01M | 15.91M | -58.89M | 21.25M | -5.11M | 58.72M | 25.42M | -111.41M | -114.82M | -126.62M | -151.51M | -9.19M | 31.88M | -51.73M | 106.12M |
Free Cash Flow | -173.6M | -198.12M | -200.99M | -217.93M | -228.93M | -227.48M | -239.25M | -249.15M | -241.49M | -223.25M | -225.71M | -208.09M | -212.44M | -220.61M | -206.26M | -187.47M | -193.07M | -183.78M |